Join us for the Policy Summit Sept. 25-26 at the Washington Marriott Georgetown in Washington, D.C.!
The webinars in this series are designed to inform patients, patient advocates, families, and the public about various aspects of gene therapy.
The fourth in a series of five educational webinars from ASGCT and the National Organization for Rare Disorders (NORD), is now available to watch for free.
DOWNLOAD THE SLIDES HERE
This session, held on Nov. 20, covered how patients are identified as candidates for gene therapy, who may be on a gene therapy treatment team, how long the procedure takes, and what to expect during recovery and longer term follow up. Participants heard from ASGCT Members Jerry Mendell, M.D., who has focused his clinical work on neuromuscular diseases for the past five decades; and Barry Byrne, M.D., Ph.D., a pediatric cardiologist who has focused on conditions that lead to skeletal muscle weakness and abnormalities in heart and respiratory function. To learn more about the process of gene therapy, visit our Patient Education portal.
Mark your calendar for the last session in this series, "Life After Gene Therapy," which will be held on Wednesday, December 18. If you missed the first three webinars, you can watch them on this section of our website.
Sept. 25-26, 2025 | Washington, D.C.
© 2000-2025 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico